{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:51:58Z","timestamp":1791157918047,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key research and development plan project supporting local special funds in the field of comprehensive health of Hubei Province","award":["2022BCE029"],"award-info":[{"award-number":["2022BCE029"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03250-x","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:24:23Z","timestamp":1783646663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic variation of human papillomavirus type 39 E6 and E7 genes in central China"],"prefix":"10.1186","volume":"23","author":[{"given":"Keying","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoru","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"3250_CR1","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1016\/j.clon.2021.07.001","volume":"33","author":"U Mahantshetty","year":"2021","unstructured":"Mahantshetty U, Lavanya G, Grover S, et al. Incidence, Treatment and Outcomes of Cervical Cancer in Low- and Middle-income Countries. Clin Oncol. 2021;33:e363\u201371.","journal-title":"Clin Oncol"},{"key":"3250_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3250_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ijc.35369","volume":"157","author":"Z Li","year":"2025","unstructured":"Li Z, Liu P, Yin A, et al. Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer. Intl J Cancer. 2025;157:288\u201397.","journal-title":"Intl J Cancer"},{"key":"3250_CR4","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","volume":"137","author":"Y Wu","year":"2024","unstructured":"Wu Y, He S, Cao M, et al. Comparative analysis of cancer statistics in China and the United States in 2024. Chin Med J. 2024;137:3093\u2013100.","journal-title":"Chin Med J"},{"key":"3250_CR5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/microorganisms13051000","volume":"13","author":"LA Pavelescu","year":"2025","unstructured":"Pavelescu LA, Mititelu-Zafiu NL, Mindru DE, et al. Molecular Insights into HPV-Driven Cervical Cancer: Oncoproteins, Immune Evasion, and Epigenetic Modifications. Microorganisms. 2025;13:1000.","journal-title":"Microorganisms"},{"key":"3250_CR6","doi-asserted-by":"publisher","first-page":"9214","DOI":"10.3390\/ijms26189214","volume":"26","author":"J Li","year":"2025","unstructured":"Li J, Li S. From Viral Infection to Genome Reshaping: The Triggering Role of HPV Integration in Cervical Cancer. IJMS. 2025;26:9214.","journal-title":"IJMS"},{"key":"3250_CR7","first-page":"8463","volume":"26","author":"L Boldeanu","year":"2025","unstructured":"Boldeanu L, Assani M-Z, Boldeanu MV, et al. Cervical Cancer in the Era of HPV: Translating Molecular Mechanisms into Preventive. Public Health Action IJMS. 2025;26:8463.","journal-title":"Public Health Action IJMS"},{"key":"3250_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3250_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.30699\/ijmm.18.3.148","volume":"18","author":"E Behboudi","year":"2024","unstructured":"Behboudi E, Charostad J, Nakhaie M, et al. JNK Signaling Pathways and Oncoviruses. Iran J Med Microbiol. 2024;18:148\u201362.","journal-title":"Iran J Med Microbiol"},{"key":"3250_CR10","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ygyno.2008.07.045","volume":"110","author":"X Castellsagu\u00e9","year":"2008","unstructured":"Castellsagu\u00e9 X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110:S4\u20137.","journal-title":"Gynecol Oncol"},{"key":"3250_CR11","first-page":"997","volume":"78","author":"H Razavi-Nikoo","year":"2023","unstructured":"Razavi-Nikoo H, Behboudi E, Aghcheli B, et al. Bac to Bac System Efficiency for Preparing HPV Type 16 Virus-Like Particle Vaccine. Arch Razi Inst. 2023;78:997\u20131003.","journal-title":"Arch Razi Inst"},{"key":"3250_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41571-024-00904-z","volume":"21","author":"T Malag\u00f3n","year":"2024","unstructured":"Malag\u00f3n T, Franco EL, Tejada R, et al. Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nat Rev Clin Oncol. 2024;21:522\u201338.","journal-title":"Nat Rev Clin Oncol"},{"key":"3250_CR13","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, et al. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings. J INFECT DIS. 2010;202:1789\u201399.","journal-title":"J INFECT DIS"},{"key":"3250_CR14","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S De Sanjose","year":"2010","unstructured":"De Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048\u201356.","journal-title":"Lancet Oncol"},{"key":"3250_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.virol.2013.04.023","volume":"445","author":"E-M De Villiers","year":"2013","unstructured":"De Villiers E-M. Cross-roads in the classification of papillomaviruses. Virology. 2013;445:2\u201310.","journal-title":"Virology"},{"key":"3250_CR16","doi-asserted-by":"publisher","first-page":"20160273","DOI":"10.1098\/rstb.2016.0273","volume":"372","author":"AA McBride","year":"2017","unstructured":"McBride AA. Oncogenic human papillomaviruses. Phil Trans R Soc B. 2017;372:20160273.","journal-title":"Phil Trans R Soc B"},{"key":"3250_CR17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.7150\/jca.14971","volume":"7","author":"Z Zeng","year":"2016","unstructured":"Zeng Z, Yang H, Li Z, et al. Prevalence and Genotype Distribution of HPV Infection in China: Analysis of 51,345 HPV Genotyping Results from China\u2019s Largest CAP Certified Laboratory. J Cancer. 2016;7:1037\u201343.","journal-title":"J Cancer"},{"key":"3250_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12985-024-02424-9","volume":"21","author":"T Li","year":"2024","unstructured":"Li T, Yang Z, Luo P, et al. Genetic variability of human papillomavirus type 18 based on E6, E7 and L1 genes in central China. Virol J. 2024;21:152.","journal-title":"Virol J"},{"key":"3250_CR19","unstructured":"Zhang Yuxiao Y, Yijuan W, Li et al. Genetic variation analyses of human papillomavirus 39 and prediction of T and B Cell epitopes. Chin J Experimental Clin Virol. 2025;39:9\u201317."},{"key":"3250_CR20","doi-asserted-by":"publisher","first-page":"e00117","DOI":"10.1128\/spectrum.00117-22","volume":"10","author":"A Karimi","year":"2022","unstructured":"Karimi A, Mohebbi E, Mckay-Chopin S, et al. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran. Microbiol Spectr. 2022;10:e00117\u201322.","journal-title":"Microbiol Spectr"},{"key":"3250_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/14647273.2018.1463570","volume":"22","author":"E Behboudi","year":"2019","unstructured":"Behboudi E, Mokhtari-Azad T, Yavarian J, et al. Molecular detection of HHV1-5, AAV and HPV in semen specimens and their impact on male fertility. Hum Fertility. 2019;22:133\u20138.","journal-title":"Hum Fertility"},{"key":"3250_CR22","unstructured":"Schiffman M, Castle PE, Jeronimo J et al. Human papillomavirus and cervical cancer n.d."},{"key":"3250_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tim.2017.07.007","volume":"26","author":"K Hoppe-Seyler","year":"2018","unstructured":"Hoppe-Seyler K, Bossler F, Braun JA, et al. The HPV E6\/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets. Trends Microbiol. 2018;26:158\u201368.","journal-title":"Trends Microbiol"},{"key":"3250_CR24","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C De Martel","year":"2017","unstructured":"De Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Intl J Cancer. 2017;141:664\u201370.","journal-title":"Intl J Cancer"},{"key":"3250_CR25","doi-asserted-by":"publisher","first-page":"1130226","DOI":"10.3389\/fmicb.2023.1130226","volume":"14","author":"Y Shen","year":"2023","unstructured":"Shen Y, Huang Y, Wang W, et al. Prevalence and genotype distribution of HPV infection among women in Xiamen, China. Front Microbiol. 2023;14:1130226.","journal-title":"Front Microbiol"},{"key":"3250_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/jmv.27359","volume":"94","author":"ME Totaro","year":"2022","unstructured":"Totaro ME, Gili JA, Liotta DJ, et al. Genetic variation in the E6 and E7 genes of human papillomavirus type 16 in northeastern Argentina. J Med Virol. 2022;94:745\u201351.","journal-title":"J Med Virol"},{"key":"3250_CR27","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/ijc.27932","volume":"132","author":"PKS Chan","year":"2013","unstructured":"Chan PKS, Zhang C, Park J, et al. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. Intl J Cancer. 2013;132:2528\u201336.","journal-title":"Intl J Cancer"},{"key":"3250_CR28","doi-asserted-by":"publisher","first-page":"e0168178","DOI":"10.1371\/journal.pone.0168178","volume":"11","author":"YJ Choi","year":"2016","unstructured":"Choi YJ, Ki EY, Zhang C, et al. Analysis of Sequence Variation and Risk Association of Human Papillomavirus 52 Variants Circulating in Korea. PLoS ONE. 2016;11:e0168178.","journal-title":"PLoS ONE"},{"key":"3250_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12985-021-01528-w","volume":"18","author":"J He","year":"2021","unstructured":"He J, Li T, Wang Y, et al. Genetic variability of human papillomavirus type 39 based on E6, E7 and L1 genes in Southwest China. Virol J. 2021;18:72.","journal-title":"Virol J"},{"key":"3250_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12985-021-01619-8","volume":"18","author":"N Hosseini","year":"2021","unstructured":"Hosseini N, Shoja Z, Arashkia A, et al. Lineage analysis of human papillomavirus type 39 in cervical samples of Iranian women. Virol J. 2021;18:152.","journal-title":"Virol J"},{"key":"3250_CR31","doi-asserted-by":"publisher","first-page":"e15877","DOI":"10.1371\/journal.pone.0015877","volume":"5","author":"KW J\u00f8rgensen","year":"2010","unstructured":"J\u00f8rgensen KW, Buus S, Nielsen M. Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes. PLoS ONE. 2010;5:e15877.","journal-title":"PLoS ONE"},{"key":"3250_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","volume":"445","author":"RD Burk","year":"2013","unstructured":"Burk RD, Harari A, Chen Z. Human papillomavirus genome variants. Virology. 2013;445:232\u201343.","journal-title":"Virology"},{"key":"3250_CR33","doi-asserted-by":"publisher","first-page":"e72565","DOI":"10.1371\/journal.pone.0072565","volume":"8","author":"Z Chen","year":"2013","unstructured":"Chen Z, Schiffman M, Herrero R, et al. Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS ONE. 2013;8:e72565.","journal-title":"PLoS ONE"},{"key":"3250_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.vaccine.2004.05.013","volume":"23","author":"I Frazer","year":"2004","unstructured":"Frazer I, Quinn M, Nicklin J, et al. Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia. Vaccine. 2004;23:172\u201381.","journal-title":"Vaccine"},{"key":"3250_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/vaccines10010053","volume":"10","author":"A Akhatova","year":"2021","unstructured":"Akhatova A, Chan CK, Azizan A, et al. The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer. Syst Rev Vaccines. 2021;10:53.","journal-title":"Syst Rev Vaccines"},{"key":"3250_CR36","doi-asserted-by":"publisher","first-page":"1192385","DOI":"10.3389\/fimmu.2023.1192385","volume":"14","author":"D Hu","year":"2023","unstructured":"Hu D, Irving AT. Massively-multiplexed epitope mapping techniques for viral antigen discovery. Front Immunol. 2023;14:1192385.","journal-title":"Front Immunol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03250-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03250-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03250-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:11:33Z","timestamp":1791155493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03250-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3250"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03250-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Jingzhou Hospital Affiliated to Yangtze University, and all the work followed the ethics guidelines of the hospital. The ethical approval number is 2022-048-01. Informed consent of patients had been obtained, and the privacy of the study subjects was protected before sample collection.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not application.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"236"}}